Allergan, Inc. (NYSE:AGN) said in a statement and said that its board of directors will be considering the new offer. It bid its shareholders to refrain from taking action yet. Allergan, Inc. (NYSE:AGN) net profit margin is 18.50% and weekly performance is 3.19%. On last trading day company shares ended up $172.25. Analysts mean target price for the company is $184.00. Allergan, Inc. (NYSE:AGN) distance from 50-day simple moving average (SMA50) is 17.44%.
Broadcom Corporation (NASDAQ:BRCM) announced it is exploring strategic alternatives for its cellular baseband business, including a potential sale or wind-down. The company has engaged investment bank JP Morgan in connection with its efforts. Broadcom Corporation (NASDAQ:BRCM) shares advanced 9.32% in last trading session and ended the day on $34.84. BRCM Gross Margin is 50.50% and its return on assets is 3.50%. Broadcom Corporation (NASDAQ:BRCM) quarterly performance is 17.54%.
American Realty Capital Healthcare Trust, Inc. (NASDAQ:HCT) ‘s shareholders are expected to own about eight percent of Ventas’s 321 million common shares then outstanding. The transaction may close in the fourth quarter of 2014. The transaction may close in the third quarter of 2014. American Realty Capital Healthcare Trust, Inc. (NASDAQ:HCT) shares moved up 9.65% in last trading session and was closed at $10.91, while trading in range of $10.65 – $10.99. American Realty Capital Healthcare Trust, Inc. (NASDAQ:HCT) year to date (YTD) performance is 4.00%.
On 29 MAY Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has raised its bid offer for Allergan, Inc. (NYSE:AGN). The takeover offer is raised with more cash. The new takeover offer is $49.4 billion. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) ended the last trading day at $134.17. Company weekly volatility is calculated as 4.65% and price to cash ratio as 77.71. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) showed a positive weekly performance of 0.53%.
Krispy Kreme Doughnuts (NYSE:KKD) reported $0.23 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.23. The company had revenue of $121.60 million for the quarter, compared to the consensus estimate of $125.53 million. During the same quarter in the previous year, the company posted $0.20 earnings per share. The company’s revenue for the quarter was up .8% on a year-over-year basis. Analysts expect that Krispy Kreme Doughnuts will post $0.78 EPS for the current fiscal year. Krispy Kreme Doughnuts (NYSE:KKD) net profit margin is 7.50% and weekly performance is 1.12%. On last trading day company shares ended up $19.00. Analysts mean target price for the company is $25.57. Krispy Kreme Doughnuts (NYSE:KKD) distance from 50-day simple moving average (SMA50) is 6.13%.
Leave a Reply